USPTO serial 79338773
CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FOSDICK, GEOFFREY A
- Law office
- TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business planning; providing market intelligence services | ACTIVE | — |
| 040 | Cryopreservation services; custom manufacture of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical research and development; the research and development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; development of biotechnological products for therapeutic use in the diagnosis, treatment, mitigation or prevention of disease, disorder or abnormal physical state or their symptoms; providing medical and scientific research information in the field of clinical trials; clinical trials; genetic testing for scientific research purposes; genetic engineering; genetic testing for scientific research purposes | ACTIVE | — |
| 045 | Reviewing standards and practices to assure compliance with regulations related to the research, development, manufacture and sale of products in the health care and medical fields and the administration of health care services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Centre for Commercialization of Regenerative Medicine
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 11, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 22, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 22, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 16, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 27, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 21, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 21, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 21, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 7, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 9, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 19, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 19, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 6, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 21, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |